Tuberculosis: The Global Cost of Diagnosis 2000

2. The Context: Estimates for the Overall Diagnostics Market
Table 1. Worldwide In Vitro Diagnostics Sales Per Capita - 1996-2002
2.1 Diagnostic Testing
Table 2. Proportionate Market Share of the Main IVD Companies - 1998
Table 3. Worldwide In Vitro Diagnostics - Sales by Country - 1996-2002
Table 4. Global Medical Technology Market by Product Grouping - 1996
2.2 Infectious Disease as a proportion of the total
Table 5. Worldwide In Vitro Diagnostics - Sales by Product Type - 1996-2002
Table 6. Worldwide Nucleic Acid Assay Sales by Test Category - 1996-2002
Table 7. Rapid Microbiology Test and Instrument Market - W. Europe - 1990-2000
2.3 Main Market Trends

3. Diagnosing Tuberculosis in Humans
Figure 1. Reported TB Cases by World Region (% of Total) - 1997
3.1 Population
3.2 Estimated number of cases of TB
3.3 Regional variations
3.3.1 Developed World (Population 790 million)
3.3.2 Middle Developed World (Population 3 billion)
3.3.4 Under-developed World (Population over 2 billion)
Table 8. Existing Market for Diagnosis of TB and Potential Additional Market for the Diagnosis of TB (if all WHO estimated cases are tested)

4. Diagnosing Paratuberculosis in Cattle, Sheep and Goats
Table 9. Proportional breakdown of highest level of diagnosis by source
4.1 Explanation of Basis for Assumptions and Variables
4.1.1 Region
4.1.2 Proportion of species in affected operations
4.1.3 Proportion of cases in which diagnosis by testing is likely to be used
4.1.4 Cost of Tuberculin Testing per Animal
Table 10. Herd and Total Cattle Tests in Great Britain since 1995
Table 11. Costs Breakdown of Bovine TB Control Programme in Great Britain - 1996-97
4.1.5 Total cost of all animals likely to be properly 'tested'
4.1.6 Cost of testing all animals in affected operations
Table 12. Current and Potential Market estimates for testing of Sheep Cattle and Goats for Paratuberculosis 1998

5. Diagnosing M. bovis in Cattle
Figure 2. Bovine Tuberculosis Occurrence, Africa.
Figure 3. Control measures for Bovine Tuberculosis based on test-and-slaughter policy and disease notification, Africa.
Figure 4. Bovine Tuberculosis Occurrence, Asia
Figure 5. Control measures for Bovine Tuberculosis based on test-and-slaughter policy and disease notification, Asia
Figure 6. Bovine Tuberculosis Occurrence, Latin America and the Caribbean
Figure 7. Control measures for Bovine Tuberculosis based on test-and-slaughter policy and disease notification, Latin America and the Caribbean
Table 13. Cattle Numbers - World - 1998
5.1 Estimated Value of Testing for Mycobacterium Bovis in Cattle
Table 14. Herd and Total Cattle Tests in Great Britain since 1995
5.1.1 Proportion of Animals Tested
5.1.2 Proportion of cases in which Laboratory Diagnosis is likely
5.1.3 Cost of testing
Table 15. Diagnosis of Bovine TB, 1998

6. Other TB Testing related markets
Figure 8. M. avium Subtypes
6.1 Avian Tuberculosis - Summary
6.2 HIV and Tuberculosis
Table 16. Estimated human tuberculosis and HIV-attributable tuberculosis cases in 1990, 1995 and 2000, by region
6.3 Extension of testing application
6.4 Summary of Diagnostic Techniques
6.4.1 RFLP
6.4.2 PCR
6.4.3 DNA Probes
6.4.4 Immunohistochemistry
6.4.5 Immunoblotting
6.4.6 Antigen-capture enzyme-linked immunosorbent assay
6.4.7 Antibody Detection

7. Conclusions
Table 17. Market Estimate - 1999
Table 18. Existing versus potential Market

8. Future prospects:
Table 19. Increasing incidence of TB
Table 20. Forecast estimates for the TB testing market 1998-2002

9. Glossary

10. Sources
10.1 Publications:
10.2 Organisations:

11. For More Information